Danghui Yu
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 3
- Inflammatory Biomarkers in Disease Prognosis 1
- Pancreatic and Hepatic Oncology Research 1
- Co-authors
- Ming-hua Zhu (6 shared papers)Chenyan Zhao (4 shared papers)Min Shi (3 shared papers)Shu‐Hui Zhang (2 shared papers)Jing Zhang (3 shared papers)Qinghua Liu (3 shared papers)Can-rong Ni (3 shared papers)Zhi Zhu (1 shared paper)
- Journals
- PLoS ONE (2 papers)Oncology Reports (2 papers)Cancer Letters (1 paper)The Lancet (1 paper)OncoImmunology (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Danghui Yu
11 papers receiving 406 citations
Peers
Comparison fields: 5 of 65
- Cancer Research 147
- Medical Terminology 1
- Oncology 93
- Molecular Biology 220
- Immunology 60
Countries citing papers authored by Danghui Yu
This map shows the geographic impact of Danghui Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danghui Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danghui Yu more than expected).
Fields of papers citing papers by Danghui Yu
This network shows the impact of papers produced by Danghui Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danghui Yu. The network helps show where Danghui Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Danghui Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 104 | |
| 2 | 2013 | 81 | |
| 3 | 2013 | 68 | |
| 4 | 2017 | 59 | |
| 5 | 2010 | 27 | |
| 6 | 2010 | 19 | |
| 7 | Fluctuations in the rate of autopsy in China. | 2011 | 18 |
| 8 | 2009 | 15 | |
| 9 | 2011 | 14 | |
| 10 | 2025 | 3 | |
| 11 | [Hepatitis B virus X protein inhibits hepatoma cell growth in vitro through p14(ARF)-dependent and p14(ARF)-independent pathways]. | 2009 | 2 |
About Danghui Yu
Danghui Yu is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Epidemiology, having authored 11 papers that have together received 410 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (2 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Autopsy Techniques and Outcomes (1 paper), Hepatitis B Virus Studies (1 paper), Pancreatitis Pathology and Treatment (1 paper) and Statistical Methods in Clinical Trials (1 paper). The work is most often cited by research in Cancer Research (147 citations), Medical Terminology (1 citation), Oncology (93 citations), Molecular Biology (220 citations) and Immunology (60 citations). Danghui Yu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ming-hua Zhu, Chenyan Zhao, Min Shi, Shu‐Hui Zhang, Jing Zhang, Qinghua Liu, Can-rong Ni, Zhi Zhu, Lina Liu and Yongmei Li. Their work appears in journals such as PLoS ONE, Oncology Reports, Cancer Letters, The Lancet and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.